Journal Menu
► ▼ Journal Menu-
- JCM Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
30 July 2025
Journal of Clinical Medicine | Title Story Articles for the First Half of 2025
We are delighted to present a list of title story articles selected for display at the top of the homepage of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) for the first half of 2025. These articles cover a wide range of topics at the heart of the most recent trends in medical research, including heart failure, HPV infection, septic cardiomyopathy, and vasculitis, to name a few. All of these articles can be accessed online by clicking on the appropriate link. We hope that medical practitioners, researchers, and those who are curious about medical knowledge can be inspired by these articles.
- “Heart Failure in Older Patients: An Update”
by Massimo Montalto, Federica D'Ignazio, Sara Camilli, Silvino Di Francesco, Marco Fedele, Francesco Landi and Antonella Gallo
J. Clin. Med. 2024, 14(6), 1982; https://doi.org/10.3390/jcm14061982
Full text available online: https://www.mdpi.com/2077-0383/14/6/1982 - “HPV Infection in Children and Adolescents—A Comprehensive Review”
by Paulina Tomecka, Anna Karwowska, Jacek Kuźnicki, Katarzyna Skinderowicz, Aleksandra Wojno, Kornelia Markut, Paulina Typek, Urszula Ciesielska, Julita Kulbacka and Małgorzata Drąg-Zalesińska
J. Clin. Med. 2024, 14(7), 2425; https://doi.org/10.3390/jcm14072425
Full text available online: https://www.mdpi.com/2077-0383/14/7/2425 - “Perspective on Renal Involvement in Antiphospholipid Syndrome: Implications for Diagnosis, Pathogenesis, and Treatment”
by Ariela Hoxha, Dorella Del Prete, Irene Condonato, Francesca K. Martino, Marco Lovisotto, Federico Nalesso and Paolo Simioni
J. Clin. Med. 2024, 14(10), 3326; https://doi.org/10.3390/jcm14103326
Full text available online: https://www.mdpi.com/2077-0383/14/10/3326 - “Attention-Deficit/Hyperactivity Disorder Symptoms Are Common and Associated with Worse Glycemic Control in Adults with Type 1 Diabetes”
by Yanli Zhang-James, Dan Draytsel, Ben Carguello, Stephen V. Faraone and Ruth S. Weinstock
J. Clin. Med. 2024, 14(10), 3606; https://doi.org/10.3390/jcm14103606
Full text available online: https://www.mdpi.com/2077-0383/14/10/3606 - “Minimally Invasive Surgery for Spontaneous Intracerebral Hemorrhage: A Review”
by Nourou Dine Adeniran Bankole, Cyrille Kuntz, Alexia Planty-Bonjour, Quentin Beaufort, Thomas Gaberel, Charlotte Cordonnier, Marco Pasi, Frieder Schlunk, Jawed Nawabi and Ilyess Zemmoura et al.
J. Clin. Med. 2024, 14(4), 1155; https://doi.org/10.3390/jcm14041155
Full text available online: http://dx.doi.org/10.3390/jcm14041155 - “Septic Cardiomyopathy: Difficult Definition, Challenging Diagnosis, Unclear Treatment”
by George E. Zakynthinos, Grigorios Giamouzis, Andrew Xanthopoulos, Evangelos Oikonomou, Konstantinos Kalogeras, Nikitas Karavidas, Ilias E. Dimeas, Ioannis Gialamas, Maria Ioanna Gounaridi, Gerasimos Siasos et al.
J. Clin. Med. 2024, 14(3), 986; https://doi.org/10.3390/jcm14030986
Full text available online: http://dx.doi.org/10.3390/jcm14030986 - “Differential Fatigue Profile in Patients with Post-COVID Condition, Fibromyalgia, and Multiple Sclerosis”
by Silvia Oliver-Mas, Jordi A. Matias-Guiu, Cristina Delgado-Alonso, Constanza Cuevas, José Manuel Alcalá Ramírez del Puerto, Juan Ignacio López-Carbonero, Jorge Matias-Guiu and Maria Diez-Cirarda
J. Clin. Med. 2024, 14(3), 952; https://doi.org/10.3390/jcm14030952
Full text available online: http://dx.doi.org/10.3390/jcm14030952 - “Culprit-Lesion Drug-Coated-Balloon Percutaneous Coronary Intervention in Patients Presenting with ST-Elevation Myocardial Infarction (STEMI)”
by Jorge Sanz-Sánchez, Andrea Teira Calderón, David Neves, Carlos Cortés Villar, Antonela Lukic, Eva Rumiz González, Guillermo Sánchez-Elvira, Lino Patricio, José Luis Díez-Gil, Héctor M. García-García et al.
J. Clin. Med. 2024, 14(3), 869; https://doi.org/10.3390/jcm14030869
Full text available online: http://dx.doi.org/10.3390/jcm14030869 - “How We Treat ANCA-Associated Vasculitis: A Focus on the Maintenance Therapy”
by Dario Roccatello, Roberta Fenoglio, Emanuele De Simone and Savino Sciascia
J. Clin. Med. 2024, 14(1), 208; https://doi.org/10.3390/jcm14010208
Full text available online: http://dx.doi.org/10.3390/jcm14010208 - “Advanced Lung Cancer Inflammation Index as Predictor of All-Cause Mortality in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention”
by Giancarlo Trimarchi, Fausto Pizzino, Alessio Lilli, Alberto Ranieri De Caterina, Augusto Esposito, Stefano Dalmiani, Annamaria Mazzone, Gianluca Di Bella, Sergio Berti and Umberto Paradossi
J. Clin. Med. 2023, 13(20), 6059; https://doi.org/10.3390/jcm13206059
Full text available online: https://www.mdpi.com/2077-0383/13/20/6059 - “Kidney Stones of Type I vs. Type II Diabetic Patients: Are There Any Differences?”
by Cătălin Pricop, Marius Ivănuță, Mihaela Nikolic and Dragoş Puia
J. Clin. Med. 2023, 13(20), 6110; https://doi.org/10.3390/jcm13206110
Full text available online: https://www.mdpi.com/2077-0383/13/20/6110 - “Hybrid and Endovascular Management of Aortic Arch Pathology”
by Richard Shi and Mathew Wooster
J. Clin. Med. 2023, 13(20), 6248; https://doi.org/10.3390/jcm13206248
Full text available online: https://www.mdpi.com/2077-0383/13/20/6248 - “Novel Minimally Invasive Surgical Approaches to Endometriosis and Adenomyosis: A Comprehensive Review”
by Flávia Ribeiro and Hélder Ferreira
J. Clin. Med. 2023, 13(22), 6844; https://doi.org/10.3390/jcm13226844
Full text available online: https://www.mdpi.com/2077-0383/13/22/6844 - “Diagnosis and Treatment of Acute Heart Failure: A Retrospective Observational Study and Medical Audit”
by Justas Suchina, Giorgia Lüthi-Corridori, Fabienne Jaun, Jörg D. Leuppi and Maria Boesing
J. Clin. Med. 2023, 13(19), 5951; https://doi.org/10.3390/jcm13195951<
Full text available online: https://www.mdpi.com/2077-0383/13/19/5951 - “High-Volume Hemodiafiltration Versus High-Flux Hemodialysis: A Narrative Review for the Clinician”
by Bernard Canaud, Giovanni Strippoli and Andrew Davenport
J. Clin. Med. 2024, 14(8), 2614; https://doi.org/10.3390/jcm14082614
Full text available online: https://www.mdpi.com/2077-0383/14/8/2614
To access more journal information, please click the following link: https://www.mdpi.com/journal/jcm.
JCM Editorial Office
29 July 2025
Meet Us at the 61st Annual Meeting European Association for the Study of Diabetes (EASD 2025), 15–19 September 2025, Vienna, Austria
Conference: 61st Annual Meeting European Association for the Study of Diabetes (EASD 2025)
Date: 15–19 September 2025
Location: Vienna, Austria
MDPI will be attending the 61st Annual Meeting European Association for the Study of Diabetes (EASD 2025), which will be held from 15 to 19 September 2025, as an exhibitor. We welcome researchers from diverse backgrounds to attend and share their latest ideas with us.
The EASD Annual Meeting is an excellent opportunity to stay up to date with recent developments in the diabetes field. The programme features groundbreaking basic research, cutting-edge clinical trial results and in-depth expert debates. We are pleased to attend the conference and also meet with colleagues from around the world and be part of the key discussions that will shape the future of diabetes research and care. Your participation will significantly contribute to the medical discourse and enhance the conference’s impact within the diabetes field.
The following open access journals will be represented at the conference:
- Biomedicines;
- Diabetology;
- JCM;
- Medicina;
- IJERPH;
- Obesities;
- Nutrients;
- Biomolecules;
- LabMed;
- Lipidology;
- Metabolites;
- Endocrines.
If you are planning to attend the above conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.easd.org/annual-meeting/easd-2025.html.
28 July 2025
World Hepatitis Day—“Hepatitis: Let’s Break It Down”, 28 July 2025
World Hepatitis Day is observed each year on 28 July to raise awareness of viral hepatitis, a type of inflammation of the liver that causes severe liver disease and liver cancer.
The theme for 2025—“Hepatitis: Let’s Break It Down”—calls for urgent action to dismantle the financial, social and systemic barriers, including stigma, that stand in the way of hepatitis elimination and liver cancer prevention.
Chronic hepatitis B and C silently cause liver damage and cancer—despite them being preventable, treatable, and, in the case of hepatitis C, curable. The theme emphasizes the need to simplify, scale up, and integrate hepatitis services—vaccination, safe injection practices, harm reduction and especially testing and treatment—into national health systems.
The campaign is a reminder that we must act now to expand access, integrate care, and end hepatitis as a public health problem by 2030.
In recognition of this important day, we recommend the following related articles, Special Issues, and journals spanning multidisciplinary fields, including clinical medicine. We believe that promoting such research contributes to enhanced public awareness and a greater understanding of viral hepatitis, an inflammation of the liver that causes severe liver disease and liver cancer.

|
Biology & Life Sciences |
Medicine & Pharmacology |

“Curcumin Nanocarriers in the Protection Against Iron- and Alcohol-Induced Oxidative Stress in a Cellular Model of Liver Disease”
by Lucy Petagine, Mohammed G. Zariwala, Satyanarayana Somavarapu, Stefanie Ho Yi Chan and Vinood B. Patel
Biology 2025, 14(5), 455; https://doi.org/10.3390/biology14050455
“Hepatic Estrogen Receptor Alpha Overexpression Protects Against Hepatic Insulin Resistance and MASLD”
by Ester S. Alves, Jessica D. M. Santos, Alessandra G. Cruz, Felipe N. Camargo, Carlos H. Z. Talarico, Anne R. M. Santos, Carlos A. A. Silva, Henrique J. N. Morgan, Sandro L. Matos, Layanne C. C. Araujo et al.
Pathophysiology 2025, 32(1), 1; https://doi.org/10.3390/pathophysiology32010001
“Change in Estimated Glomerular Filtration Rate After Direct-Acting Antiviral Treatment in Chronic Hepatitis C Patients”
by Gantogtokh Dashjamts, Amin-Erdene Ganzorig, Yumchinsuren Tsedendorj, Dolgion Daramjav, Enkhmend Khayankhyarvaa, Bolor Ulziitsogt, Otgongerel Nergui, Ganchimeg Dondov, Tegshjargal Badamjav, Tulgaa Lonjid et al.
Diseases 2025, 13(2), 26; https://doi.org/10.3390/diseases13020026
“Effects of SARS-CoV-2 Spike S1 Subunit on the Interplay Between Hepatitis B and Hepatocellular Carcinoma Related Molecular Processes in Human Liver”
by Giovanni Colonna
Livers 2025, 5(1), 1; https://doi.org/10.3390/livers5010001
“Liver Cancer Neuroscience: Regulating Liver Tumors via Selective Hepatic Vagotomy”
by Kylynda C. Bauer, Shadin Ghabra, Chi Ma Lee Chedester and Tim F. Greten
Methods Protoc. 2024, 7(6), 99; https://doi.org/10.3390/mps7060099
“Role of Circulating microRNAs in Liver Disease and HCC: Focus on miR-122”
by Francesco Colaianni, Veronica Zelli, Chiara Compagnoni, Martina Sara Miscione, Mario Rossi, Davide Vecchiotti, Monica Di Padova, Edoardo Alesse, Francesca Zazzeroni and Alessandra Tessitore
Genes 2024, 15(10), 1313; https://doi.org/10.3390/genes15101313
“Impact of Hepatitis Delta Virus Infection on the Selection of Hepatitis B Surface Antigen Mutations”
by Kabo Baruti,Wonderful T. Choga, Bonolo B. Phinius, Basetsana Phakedi, Lynnette Bhebhe, Gorata G. A. Mpebe, Patience C. Motshosi, Tsholofelo Ratsoma, Sikhulile Moyo, Mosimanegape Jongman et al.
Genes 2024, 15(8), 982; https://doi.org/10.3390/genes15080982
“NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment Options”
by Natalia G. Vallianou, Dimitris Kounatidis, Sotiria Psallida, Nikolaos Vythoulkas-Biotis, Andreas Adamou, Tatiana Zachariadou, Sofia Kargioti, Irene Karampela and Maria Dalamaga
Metabolites 2024, 14(7), 366; https://doi.org/10.3390/metabo14070366
“miRNA Expression and HCC Occurrence in HCV Cirrhotic Patients Treated with Direct Acting Antivirals”
by Antonietta Romano, Alessandra Brocca, Zoe Mariño, Sofía Pérez-del-Pulgar, Sabela Lens, Loreto Boix, María Reig, Jordi Bruix, Giulio Ceolotto, Valeria Calvino et al.
Livers 2024, 4(2), 275-286; https://doi.org/10.3390/livers4020020
“The Full-Genome Analysis and Generation of an Infectious cDNA Clone of a Genotype 6 Hepatitis E Virus Variant Obtained from a Japanese Wild Boar: In Vitro Cultivation in Human Cell Lines”
by Putu Prathiwi Primadharsini, Masaharu Takahashi, Tsutomu Nishizawa, Yukihiro Sato, Shigeo Nagashima, Kazumoto Murata and Hiroaki Okamoto
Viruses 2024, 16(6), 842; https://doi.org/10.3390/v16060842
“Hepatitis C Prevalence and Birth Outcomes among Pregnant Women in the United States: A 2010–2020 Population Study”
by Paul Wasuwanich, Songyos Rajborirug, Robert S. Egerman, Tony S. Wen and Wikrom Karnsakul
Pathogens 2024, 13(4), 321; https://doi.org/10.3390/pathogens13040321
“Prospects for Controlling Hepatitis B Globally”
by Vicente Soriano, Víctor Moreno-Torres, Ana Treviño, Fernando de Jesús, Octavio Corral and Carmen de Mendoza
Pathogens 2024, 13(4), 291; https://doi.org/10.3390/pathogens13040291
“Longterm Outcome of Therapeutic Vaccination with a Third Generation Pre-S/S HBV Vaccine (PreHevbrioR) of Chronically HBV Infected Patients”
by Hedwig Roggendorf, Daniel Shouval, Michael Roggendorf and Guido Gerken
J. Pers. Med. 2024, 14(4), 364; https://doi.org/10.3390/jpm14040364
“NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay”
by Simona Cernea
Life 2024, 14(2), 272; https://doi.org/10.3390/life14020272
“Updated Clinical Guidelines on the Management of Hepatitis C Infection in Children”
by Chaowapong Jarasvaraparn, Christopher Hartley and Wikrom Karnsakul
Pathogens 2024, 13(2), 180; https://doi.org/10.3390/pathogens13020180
“Non-Invasive Assessment of Liver Fibrosis in Hepatitis B Patients”
by Chinmay Bera, Nashla Hamdan-Perez and Keyur Patel
J. Clin. Med. 2024, 13(4), 1046; https://doi.org/10.3390/jcm13041046
“Real-World Utilization of Corticosteroids in Severe Alcoholic Hepatitis: Eligibility, Response, and Outcomes”
by Ana-Maria Singeap, Horia Minea, Oana Petrea, Madalina-Andreea Robea, Ioana-Miruna Balmuș, Raluca Duta, Ovidiu-Dumitru Ilie, Carmen Diana Cimpoesu, Carol Stanciu and Anca Trifan
Medicina 2024, 60(2), 311; https://doi.org/10.3390/medicina60020311
“Autoimmune Hepatitis: A Diagnostic and Therapeutic Overview”
by Lydia A. Mercado, Fernando Gil-Lopez, Razvan M. Chirila and Denise M. Harnois
Diagnostics 2024, 14(4), 382; https://doi.org/10.3390/diagnostics14040382
“Hepatoprotective Effects of Flavonoids against Benzo[a]Pyrene-Induced Oxidative Liver Damage along Its Metabolic Pathways”
by Min Kim, Seung-Cheol Jee and Jung-Suk Sung
Antioxidants 2024, 13(2), 180; https://doi.org/10.3390/antiox13020180
”Enhancing Liver Delivery of Gold Nanoclusters via Human Serum Albumin Encapsulation for Autoimmune Hepatitis Alleviation”
by Cong Meng, Yu Liu, Yuping Ming, Cao Lu, Yanggege Li, Yulu Zhang, Dongdong Su, Xueyun Gao and Qing Yuan
Pharmaceutics 2024, 16(1), 110; https://doi.org/10.3390/pharmaceutics16010110
“Hepatitis B Virus Reactivation with Immunosuppression: A Hidden Threat?”
by Sama Anvari and Keith Tsoi
J. Clin. Med. 2024, 13(2), 393; https://doi.org/10.3390/jcm13020393
“Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Viral Hepatitis: The Interlink”
by Cornelius J. Fernandez, Mohammed Alkhalifah, Hafsa Afsar and Joseph M. Pappachan
Pathogens 2024, 13(1), 68; https://doi.org/10.3390/pathogens13010068
“A Case Report: Idiopathic or Drug-Induced Autoimmune Hepatitis—Can We Draw a Line?”
by Dorotea Božić, Ante Tonkić, Jr,Katarina Vukojevic and Maja Radman
Clin. Pract. 2023, 13(6), 1393–1399; https://doi.org/10.3390/clinpract13060125
“Liver dECM–Gelatin Composite Bioink for Precise 3D Printing of Highly Functional Liver Tissues”
by Min Kyeong Kim, Wonwoo Jeong and Hyun-Wook Kang
J. Funct. Biomater. 2023, 14(8), 417; https://doi.org/10.3390/jfb14080417

|
“Viral Hepatitis: Diagnosis, Treatment and Management” |
“New Insights into Diagnosis and Therapeutic Strategies for Chronic Liver Diseases” |
![]() |
![]() |
|
“The Surveillance, Prevention, and Treatment of Viral Hepatitis: Looking Forward to Global Elimination” |
“Viral Hepatitis and Therapeutic Strategies” |
![]() |
![]() |
|
“Genetic Analysis of Hepatitis Virus Infection” |
“Oxidative Stress in Hepatic Diseases” |
![]() |
![]() |
|
“Viral Hepatitis Among Specific Populations: Epidemiology, Transmission, Treatment, and Prevention” |
“Biology of Liver Diseases” |
![]() |
![]() |
|
“Hepatitis E Virus (HEV) Infection Among Humans and Animals: Epidemiology, Clinical Characteristics, Treatment and Prevention—2nd Edition” |
“Human Hepatitis Viruses and Their Animal Homologues” |
![]() |
![]() |
|
“Advances in Hepatitis: Prevention, Treatment, and Global Health Impact” |
“Pathogenesis of Viral Hepatitis” |
![]() |
![]() |
|
“Liver Diseases: Diagnosis and Treatment in the Era of Personalized Medicine” |
“Gastrointestinal and Liver Diseases: New Advances in Diagnosis and Prognosis” |
![]() |
![]() |
28 July 2025
Journal of Clinical Medicine Editor of Distinction Award—Winners Announced
The editorial team of Journal of Clinical Medicine (JCM, ISSN: 2077-0383) would like to congratulate the winners of the JCM 2024 Editor of Distinction Award, who were chosen by a selection committee chaired by the Editors-in-Chief, Prof. Dr. Emmanuel Andrès and Prof. Dr. Kent Doi. Following a formal review process by the Award Evaluation Committee, six Editorial Board Members were selected as winners. The recipients are as follows:
|
|
Name: Prof. Dr. Teruhiko Imamura |
|
|
Name: Prof. Dr. Andrzej Grzybowski |
|
|
Name: Prof. Dr. Makoto Inoue |
|
|
Name: Prof. Dr. Etsuo Chihara |
|
|
Name: Prof. Dr. Andrew Day |
|
|
Name: Prof. Dr. Indre Bileviciute-Ljungar |
You can find more information about this award and how to nominate individuals here: https://www.mdpi.com/journal/jcm/awards. To request further information, please contact the JCM Editorial Office.
Journal of Clinical Medicine Editorial Office
24 July 2025
Journal of Clinical Medicine | Most Downloaded Papers in 2025
Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an open access journal, with an Impact Factor of 2.9 (2024) and 5-Year Impact Factor of 3.3 (2024), which continues to contribute to the widespread dissemination of medical research with professionalism and reliability. In the first half of 2025, the papers published by JCM have garnered significant popularity with many readers. Here, we have selected 15 high-impact papers with a high average number of downloads to form the following selected collection of recommendations. These research results cover cardiovascular disease, heart failure, diabetes, spinal trauma, hemodialysis, neurodegenerative diseases, spondyloarthritis, cervical spine disease, cardiorenal syndrome, knee replacement, pancreatic tumors, pituitary tumors, inflammatory bowel disease, cancer, and other fields. We hope this will inspire your own research.
You can find the latest research through this link: https://www.mdpi.com/search?q=&journal=jcm&sort=pubdate&page_count=50.
1. “Now and the Future: Medications Changing the Landscape of Cardiovascular Disease and Heart Failure Management”
by Thomas Oswald, Steven Coombs, Susan Ellery and Alexander Liu
J. Clin. Med. 2025, 14(11), 3948; https://doi.org/10.3390/jcm14113948
Full text available online: https://www.mdpi.com/2077-0383/14/11/3948
2. “The Relationship of the Plasma Glycated CD59 Level with Microvascular Complications in Diabetic Patients and Its Evaluation as a Predictive Marker”
by Ozgur Yilmaz, Osman Erinc, Ayca Gul Gungordu, Mehmet Erdogan, Murvet Algemi and Murat Akarsu
J. Clin. Med. 2025, 14(13), 4588; https://doi.org/10.3390/jcm14134588
Full text available online: https://www.mdpi.com/2077-0383/14/13/4588
3. “Minimally Invasive Lateral Thoracic and Lumbar Interbody Fusion with Expandable Interbody Spacers for Spine Trauma—Indications, Complications and Outcomes”
by Linda Bättig, Gregor Fischer, Benjamin Martens, Anand Veeravagu, Lorenzo Bertulli and Martin N. Stienen
J. Clin. Med. 2025, 14(13), 4557; https://doi.org/10.3390/jcm14134557
Full text available online: https://www.mdpi.com/2077-0383/14/13/4557
4. “Hemodynamic Adaptation and Cardiac Effects of High-Flow Arteriovenous Access in Hemodialysis Patients: A Prospective Study”
by Yaeni Kim, Ji-hye Kim, Juyeon Woo, Oknan Choi, Mina Lee and Sunryoung Choi
J. Clin. Med. 2025, 14(13), 4556; https://doi.org/10.3390/jcm14134556
Full text available online: https://www.mdpi.com/2077-0383/14/13/4556
5. “Visualization of the Glymphatic System Through Brain Magnetic Resonance in Human Subjects with Neurodegenerative Disorders: A Systematic Review and Meta-Analysis”
by Jana Hamzeh, Hayat Harati, Farah Ayoubi, Marie-belle Saab, Lea Saab, Elie Al Ahmar and Elias Estephan
J. Clin. Med. 2025, 14(12), 4387; https://doi.org/10.3390/jcm14124387
Full text available online: https://www.mdpi.com/2077-0383/14/12/4387
6. “Prevalence of Undiagnosed Inflammatory Bowel Disease in Spondyloarthritis Patients”
by Jesús Sanz-Sanz, Ana Gutiérrez-Casbas, Zulema Plaza, Jordi Gratacós, Iago Rodríguez-Lago, Ignacio Marín-Jiménez, Elisa Trujillo-Martín, Eva Pérez-Pampín, Manuel Barreiro-de Acosta, María Vanesa Hernández-Hernández et al.
J. Clin. Med. 2025, 14(13), 4569; https://doi.org/10.3390/jcm14134569
Full text available online: https://www.mdpi.com/2077-0383/14/13/4569
7. “Effects of Pre-Operative HbA1c on Outcomes and the Rate of Clinical Improvement Following Anterior Cervical Discectomy and Fusion”
by Ara Khoylyan, Noah Coleman, Matthew Parry, Alex Tang and Tan Chen
J. Clin. Med. 2025, 14(13), 4589; https://doi.org/10.3390/jcm14134589
Full text available online: https://www.mdpi.com/2077-0383/14/13/4589
8. “A Pragmatic Approach to Acute Cardiorenal Syndrome: Diagnostic Strategies and Targeted Therapies to Overcome Diuretic Resistance”
by Patrick Tran, Laith Khweir, Michael Kuehl, Mithilesh Joshi, Krishna Appunu, Waqar Ayub and Prithwish Banerjee
J. Clin. Med. 2025, 14(9), 2996; https://doi.org/10.3390/jcm14092996
Full text available online: https://www.mdpi.com/2077-0383/14/9/2996
9. “The Temporal–Spatial Parameters of Gait After Total Knee Arthroplasty”
by Karina Szczypiór-Piasecka, Paulina Adamczewska, Łukasz Kołodziej and Paweł Ziętek
J. Clin. Med. 2025, 14(13), 4548; https://doi.org/10.3390/jcm14134548
Full text available online: https://www.mdpi.com/2077-0383/14/13/4548
10. “Clinical Features of Intraductal Papillary Mucinous Neoplasm-Related Pancreatic Carcinomas in Long-Term Surveillance”
by Kyohei Matsuura, Shinsaku Nagamatsu, Shoma Kikukawa, Yuya Nishio, Yusuke Komeda, Yuya Matsuo, Kohei Ohta, Chisa Yamamoto, Ayana Sueki and Kei Moriya
J. Clin. Med. 2025, 14(13), 4585; https://doi.org/10.3390/jcm14134585
Full text available online: https://www.mdpi.com/2077-0383/14/13/4585
11. “Eye Selection Criteria’s Influence in the Value of Pituitary Macroadenoma Management Biomarkers: Preliminary Findings”
by Odelaisys Hernández-Echevarría, Elizabeth Bárbara Cuétara-Lugo, Mario Jesús Pérez-Benítez, Lídice Galán-García, Ibrain Piloto-Diaz and Eduardo Fernández
J. Clin. Med. 2025, 14(13), 4542; https://doi.org/10.3390/jcm14134542
Full text available online: https://www.mdpi.com/2077-0383/14/13/4542
12. “Assessing ChatGPT-v4 for Guideline-Concordant Inflammatory Bowel Disease: Accuracy, Completeness, and Temporal Drift”
by Oguz Ozturk, Mucahit Ergul, Yavuz Cagir, Ali Atay, Kadir Can Acun, Orhan Coskun, Ilyas Tenlik, Muhammed Bahaddin Durak and Ilhami Yuksel
J. Clin. Med. 2025, 14(13), 4599; https://doi.org/10.3390/jcm14134599
Full text available online: https://www.mdpi.com/2077-0383/14/13/4599
13. “Risk Factors and Prevention of Cancer and CVDs: A Chicken and Egg Situation”
by Maurizio Giuseppe Abrignani, Fabiana Lucà, Vincenzo Abrignani, Mariacarmela Nucara, Daniele Grosseto, Chiara Lestuzzi, Marinella Mistrangelo, Bruno Passaretti, Carmelo Massimiliano Rao and Iris Parrini
J. Clin. Med. 2025, 14(9), 3083; https://doi.org/10.3390/jcm14093083
Full text available online: https://www.mdpi.com/2077-0383/14/9/3083
14. “Cardiovascular–Kidney–Metabolic Syndrome: A New Paradigm in Clinical Medicine or Going Back to Basics?”
by Victoria Mutruc, Cristina Bologa, Victorița Șorodoc, Alexandr Ceasovschih, Bianca Codrina Morărașu, Laurențiu Șorodoc, Oana Elena Catar and Cătălina Lionte
J. Clin. Med. 2025, 14(8), 2833; https://doi.org/10.3390/jcm14082833
Full text available online: https://www.mdpi.com/2077-0383/14/8/2833
15. “Endoscopic-Ultrasound-Guided Radiofrequency Ablation for Pancreatic Tumors”
by Chiara Coluccio, Stefania Cappetta, Giovanna Romagnoli, Valentina Di Giorgio, Paolo Giuffrida, Stefano Fabbri, Carlo Fabbri and Cecilia Binda
J. Clin. Med. 2025, 14(2), 495; https://doi.org/10.3390/jcm14020495
Full text available online: https://www.mdpi.com/2077-0383/14/2/495
18 July 2025
Journal of Clinical Medicine Indexed in the Reaxys Database
Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has been indexed in the Reaxys database, which indicates that its academic influence is highly recognized and highlights the great value of the integration of clinical medicine and chemistry. A large number of clinical research results published by JCM provide real-world demand and feedback for disease treatment for researchers in the field of chemistry. After being included in the Reaxys database, these clinical data will be deeply integrated with chemical data.
Core highlights:
- Accelerating the research and development of new drugs
Clinical research results can help researchers quickly locate disease targets, screen lead compounds and shorten the drug development cycle;
- Optimizing clinical decision-making and individualized treatment
The cross-analysis of clinical data, physicochemical properties, and toxicological characteristics of chemicals provides data support for the optimization of clinical trial scheme and individualized treatment based on molecular characteristics;
- Deepening the research on the molecular mechanism of diseases
By integrating clinical observation data with the analysis of chemical structure–activity relationship, it will promote the analysis of disease pathogenesis at the molecular level and help the development of innovative treatment strategies;
- The promotion of academic influence and the win-win situation of resource integration
With the global exposure of the paper on Reaxys platform, it will build a high-speed communication channel for the advancement of journal impact factors and the promotion of scholars’ international academic popularity.
An additional benefit is realizing the efficient linkage of clinical medicine, pharmacy, and chemistry resources, and providing a broader platform for chemical and medical practitioners.
For more details on the journal and its indexing information, please visit the official website:
https://www.mdpi.com/journal/jcm/indexing.
We look forward to your continuous attention and joint exploration of the infinite possibilities of the integration of medicine and chemistry.
16 July 2025
Meet Us at the ESMO Congress 2025, 17–21 October 2025, Berlin, Germany
The ESMO Congress is a significant global oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. ESMO 2025 aims to converge groundbreaking discoveries, innovative treatments and collaborative approaches to shape the future of cancer care. This event provides the opportunity to learn from internationally renowned experts, engage in thought-provoking discussions and connect with fellow oncology professionals who are advancing diagnosis, treatment and survivorship in this field.
The following MDPI journals will be represented at this conference:
- Cancers;
- Current Oncology;
- Life;
- JCM;
- Hematology Reports;
- CIMB;
- Cells;
- Oral;
- Uro;
- Pharmaceuticals;
- Gastroenterology Insights;
- Diagnostics;
- Targets;
- JPM;
- Onco;
- Radiation;
- Diseases;
- Hemato;
- Livers.
If you are planning to attend the above conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at booth #P2007 and answering any questions that you may have.
For more information about this conference, please visit the following website: https://www.esmo.org/meeting-calendar/esmo-congress-2025.
14 July 2025
Meet Us Virtually at the 1st International Online Conference on Hematology, 28–30 October 2026
We cordially invite you to attend the 1st International Online Conference on Hematology organized by the MDPI journals Hematology Reports (ISSN: 2038-8330, Impact Factor 1.2), Hemato (ISSN: 2673-6357, Impact Factor 1.0), and Thalassemia Reports (ISSN: 2039-4365, Impact Factor 1.2). It will take place online from 28 to 30 October 2026, and it is free of charge for all participants.
Conference Chair:
- Prof. Dr. Claudio Cerchione, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy.
The topics of interest:
S1. Multiple Myeloma;
S2. Acute Myeloid Leukemia;
S3. Acute Lymphoblastic Leukemia;
S4. Non-Hodgkin Lymphoma;
S5. Hodgkin Lymphoma;
S6. CML and Myeloproliferative Neoplasms;
S7. Stem Cell Transplantation and New Cellular Therapies;
S8. Rare diseases.
Important dates:
Deadline for abstract submission: 29 June 2026;
Notification of acceptance: 28 July 2026;
Deadline for registration: 22 November 2026.
Guide for authors:
To submit your abstract, please click on the following link: https://sciforum.net/user/submission/create/1493.
To register for the event, please click on the following link: https://sciforum.net/event/IOCHE2026?subscribe§ion=#registration.
Note: We only accept abstracts for this conference. To publish a conference proceedings paper for free and submit a full manuscript to the organizing journals Hematology Reports (ISSN: 2038-8330, Impact Factor 1.2), Hemato (ISSN: 2673-6357, Impact Factor 1.0) and Thalassemia Reports (ISSN: 2039-4365, Impact Factor 1.2), please refer to the Publication Opportunities section.
Best Presentation Award and Best Poster Award:
- Six winners;
- Each winner will receive a certificate;
- CHF 200 each.
For any enquiries regarding this event, please contact ioche2026@mdpi.com.
We look forward to seeing you at the 1st International Online Conference on Hematology!
14 July 2025
Journal of Clinical Medicine | Highly Cited Papers Published in 2024 and Hot Topic Special Issues in the “Clinical Pediatrics” Section
Our “Clinical Pediatrics” Section of Journal of Clinical Medicine (JCM, ISSN: 2077-0383) was established in 2023, and a total of 394 papers have been published since its launch. The aim of this Section is to offer a platform to pediatric clinicians, physicians, and healthcare professionals to present cutting-edge basic and applied health research, as well as quality clinical services in general and specialty pediatrics. We invite you to explore the highly cited articles of 2024 and discover the latest research via the following link: https://www.mdpi.com/search?journal=jcm§ion=2471.
Our “Clinical Pediatrics” Section’s subject areas, including but not limited to the following:
- Neonatal medicine;
- Genetic and congenital conditions;
- Developmental–behavioral medicine;
- Pediatric surgery;
- Pediatric cardiology;
- Pediatric nephrology;
- Pediatric dermatology;
- Pediatric orthopedics;
- Pediatric stomatology;
- Pediatric infectious diseases;
- Pediatric pulmonary;
- Child and adolescent psychiatry;
- Pediatric neurology;
- Pediatric ophthalmology;
- Childhood cancer;
- Pediatric allergy and immunology;
- Pediatric endocrinology;
- Pediatric gastroenterology.
In addition, some Special Issues in the “Clinical Pediatrics” Section are currently open for submissions. The following is a list of articles and Special Issues that we believe may interest you:
1. “Candida auris Infection, a Rapidly Emerging Threat in the Neonatal Intensive Care Units: A Systematic Review”
by Rozeta Sokou, Alexia Eleftheria Palioura, Paschalia Kopanou Taliaka, Aikaterini Konstantinidi, Andreas G. Tsantes, Daniele Piovani, Konstantina A. Tsante, Eleni A. Gounari, Zoi Iliodromiti, Theodora Boutsikou et al.
J. Clin. Med. 2024, 13(6), 1586; https://doi.org/10.3390/jcm13061586
Full text available online: https://www.mdpi.com/2077-0383/13/6/1586
2. “Occlusal Caries Detection with Intraoral Scanners in Pediatric Dentistry: A Comparative Clinical Study”
by Nelly Schulz-Weidner, Marina Gruber, Bernd Wöstmann, Constanze Friederike Uebereck, Norbert Krämer and Maximiliane Amelie Schlenz
J. Clin. Med. 2024, 13(4), 925; https://doi.org/10.3390/jcm13040925
Full text available online: https://www.mdpi.com/2077-0383/13/4/925
3. “Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management”
by Paola Borgia, Gianluca Piccolo, Andrea Santangelo, Cristina Chelleri, Gianmaria Viglizzo, Corrado Occella, Carlo Minetti, Pasquale Striano and Maria Cristina Diana
J. Clin. Med. 2024, 13(6), 1792; https://doi.org/10.3390/jcm13061792
Full text available online: https://www.mdpi.com/2077-0383/13/6/1792
4. “Ultrasonic Scalpel vs. Polymeric Clip Laparoscopic Varicocelectomy in Adolescents with Symptomatic Varicocele”
by Zenon Pogorelić, Karlo Poljak, Miro Jukić and Katarina Vukojević
J. Clin. Med. 2024, 13(15), 4322; https://doi.org/10.3390/jcm13154322
Full text available online: https://www.mdpi.com/2077-0383/13/15/4322
5. “Acute Kidney Injury in Neonatal Intensive Care Unit: Epidemiology, Diagnosis and Risk Factors”
by Valeria Chirico, Antonio Lacquaniti, Filippo Tripodi, Giovanni Conti, Lucia Marseglia, Paolo Monardo, Eloisa Gitto and Roberto Chimenz
J. Clin. Med. 2024, 13(12), 3446; https://doi.org/10.3390/jcm13123446
Full text available online: https://www.mdpi.com/2077-0383/13/12/3446
6. “Malnutrition and Allergies: Tipping the Immune Balance towards Health”
by Emilia Vassilopoulou, Carina Venter and Franziska Roth-Walter
J. Clin. Med. 2024, 13(16), 4713; https://doi.org/10.3390/jcm13164713
Full text available online: https://www.mdpi.com/2077-0383/13/16/4713
7. “High-Resolution Anorectal Manometry as a Screening Tool for Hirschsprung’s Disease: A Comprehensive Retrospective Analysis”
by Oliver Sowulewski, Magdalena Bubińska, Agnieszka Zagierska, Maciej Zagierski and Agnieszka Szlagatys-Sidorkiewicz
J. Clin. Med. 2024, 13(5), 1268; https://doi.org/10.3390/jcm13051268
Full text available online: https://www.mdpi.com/2077-0383/13/5/1268
8. “Artificial Intelligence-Based Diagnostic Support System for Patent Ductus Arteriosus in Premature Infants”
by Seoyeon Park, Junhyung Moon, Hoseon Eun, Jin-Hyuk Hong and Kyoungwoo Lee
J. Clin. Med. 2024, 13(7), 2089; https://doi.org/10.3390/jcm13072089
Full text available online: https://www.mdpi.com/2077-0383/13/7/2089
9. “Barriers to Type 1 Diabetes Adherence in Adolescents”
by Sarah Azar, Noa Maroun Abou Jaoude, Andrzej Kędzia and Elżbieta Niechciał
J. Clin. Med. 2024, 13(19), 5669; https://doi.org/10.3390/jcm13195669
Full text available online: https://www.mdpi.com/2077-0383/13/19/5669
| Special Issues: | |
| “Risk Factors in Neonatal Intensive Care” Guest Editors: Prof. Dr. Gabriela C. Zaharie and Dr. Melinda Matyas Submission deadline: 20 December 2025 |
“Pediatric Neurosurgery: Clinical Advances in Diagnostics and Perioperative Management” Guest Editors: Dr. Kara Leigh Krajewski and Prof. Dr. Ulrich-Wilhelm Thomale Submission deadline: 29 December 2025 |
![]() |
![]() |
| “Cardiac and Pulmonary Involvements in High-Risk Neonatal Cohorts: Short- and Long-Term Issues” Guest Editor: Prof. Dr. Arvind Sehgal Submission deadline: 20 January 2026 |
“Endocrine Disorders in Children: 2nd Edition” Guest Editor: Dr. Juan Pedro López-Siguero Submission deadline: 20 February 2026 |
![]() |
![]() |
7 July 2025
Meet Us at the European Academy of Dermatology & Venereology (EADV) 2025, 17–20 September 2025, Paris, France
Conference: European Academy of Dermatology & Venereology (EADV) 2025
Date: 17–20 September 2025
Location: Paris, France
MDPI will attend the European Academy of Dermatology & Venereology (EADV) 2025, which will be held from 17 to 20 September 2025, as an exhibitor (booth position—A24). We welcome researchers from various backgrounds to visit our booth and share their latest ideas with us.
It is with great pride and anticipation that we welcome you to the EADV Congress 2025, set against the vibrant backdrop of Paris—a city synonymous with elegance, culture, and innovation. As we gather at the Paris Convention Centre, we unite once again to celebrate the very best in dermatology and venereology.
This year’s Congress promises to be our most dynamic yet. With over 180 scientific sessions, 600+ expert speakers, 25+ dedicated subspecialty tracks, and 10 powerful plenary lectures, our programme reflects the incredible depth and breadth of our field. We are especially excited to host abstract-based free communications, late-breaking research highlights, and a residents-targeted session, ensuring opportunities for every level of expertise and interest.
The following open access journals will be represented at the conference:
- JCM;
- Dermatopathology;
- Cosmetics;
- Diseases;
- Allergies;
- Diagnostics;
- Medicines;
- Venereology;
- Dermato;
- Medicina;
- Reports.
If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have.























